Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Itraconazole vs Continuous Terbinafine for Onychomycosis
NCT05578950Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in onychomycosis comparing Pulse Itraconazole with Continuous Terbinafine (2 arms). Primary endpoint: Onychomycosis Severity Index at 12 weeks. Started Mar 2022; status: completed.
02
Drugs
itraconazoleTerbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT05578950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05578950.